Clinical Trials Logo

Glucose Control clinical trials

View clinical trials related to Glucose Control.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03998111 Completed - Glucose Control Clinical Trials

Genetic Variation in CLTCL1 and Whole-body Glucose Control

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Maintaining stable blood glucose concentrations after eating has important implications for health. Individuals who are better able to maintain stable blood glucose concentrations after consuming carbohydrate have a lower risk of mortality from cardiovascular disease. Muscle is the primary tissue for glucose disposal following a meal, and responsiveness of this tissue to insulin is dictated by GLUT4 translocation to the muscle cell membrane. Clathrin heavy chain isoform 22 (CHC22) is a protein that plays a key role in intracellular GLUT4 action, and it may play an important role in whole-body glucose control. Genetic variation in the gene which codes for CHC22 may be able to explain differences in glucose control at the whole-body level.

NCT ID: NCT02169245 Completed - Appetite Clinical Trials

Effects of Protein and Fiber at Breakfast on Appetite, Blood Sugar, and Cholesterol

PFB
Start date: March 2014
Phase: N/A
Study type: Interventional

The objectives of the research are to assess the effects of increased protein and fiber intake at breakfast on neural activation in brain regions associated with appetitive drive and reward-driven eating, measures of subjective appetite, and ingestive behavior in overweight adults. Additional outcomes of interest include the effects of the breakfast intervention on blood sugar and cholesterol profiles.

NCT ID: NCT01041144 Completed - Type 2 Diabetes Clinical Trials

Effects of Health Care Provider-mediated, Remote Coaching System Through the PDA-type Glucometer and the Internet on Diabetes Management

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effectiveness of the new diabetes care delivery system applied to preexisting public health care resources through advanced information technologies such as PDA-type glucometer and the Internet on the glycemic control of type 2 diabetes patients lived in isolated rural area. The investigators conducted a prospective, randomized, controlled trial in patients with type 2 diabetes for 12 weeks. The intervention group was treated with the new health care delivery system, where diabetes center provided specialized management, mediated by nurse of primary health care posts using the Internet and the PDA-type glucometer, while the control group with conventional health care. HbA1c, fasting plasma glucose and lipids levels were measured at baseline and follow-up.